Discussed in this episode:
- Moderna’s got a new MRNA vaccine for influenza. It says clinical trials show the vaccine is 26% more effective than the flu vaccine currently in use. But when Moderna asked the FDA to review the new vaccine for approval, the FDA refused. Then, within a week, the FDA reversed itself and started the review.
To send us a question in advance of next week’s show, write to: [email protected]
Tune in live Monday mornings at 7:30am Pacific at kpfa.org.
Podcast music credit: Now Son by Podington Bear, licensed under a Attribution-NonCommercial 3.0 International License.